Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.098 | 0.098 |
Brugia malayi | Bromodomain containing protein | 0.0078 | 0.2714 | 0.2456 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1999 | 0.811 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0023 | 0.0231 | 0.0597 |
Entamoeba histolytica | hypothetical protein | 0.0072 | 0.2443 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0238 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.2512 | 0.2512 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0062 | 0.199 | 0.8074 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0072 | 0.2443 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0062 | 0.199 | 0.8074 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.1999 | 0.1999 |
Entamoeba histolytica | hypothetical protein | 0.0072 | 0.2443 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.014 | 0.0213 |
Brugia malayi | Bromodomain containing protein | 0.004 | 0.0977 | 0.0656 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.1999 | 0.1999 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0072 | 0.2443 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0072 | 0.2443 | 0.5 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0023 | 0.0231 | 0.0597 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0023 | 0.0231 | 0.0597 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.1999 | 0.1999 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1999 | 0.811 |
Brugia malayi | RNA binding protein | 0.0062 | 0.1999 | 0.1714 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0037 | 0.0865 | 0.3291 |
Brugia malayi | hypothetical protein | 0.0072 | 0.2443 | 0.2175 |
Schistosoma mansoni | hypothetical protein | 0.0072 | 0.2443 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1999 | 0.811 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.1999 | 0.1714 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.1999 | 0.811 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0072 | 0.2443 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0066 | 0.216 | 0.8794 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1999 | 0.811 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.1092 | 0.1092 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.1999 | 0.811 |
Entamoeba histolytica | hypothetical protein | 0.0072 | 0.2443 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0021 | 0.014 | 0.014 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.1999 | 0.1714 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0037 | 0.0865 | 0.3291 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.1183 | 0.1183 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.1999 | 0.811 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0238 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 promastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit at 10 ug/mL after 72 hrs | ChEMBL. | 19743860 | |
Inhibition (functional) | Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit at 12.5 ug/mL after 72 hrs | ChEMBL. | 19743860 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.